Skip to navigation | Skip to main content | Skip to footer
Menu
Search the Staffnet siteSearch StaffNet

Surgical device: UMANC

Trial Name: A Phase I study of a novel synthetic polymer nerve conduit ‘Polynerve’ in patients with sensory digital nerve injury

Chief Investigator: Dr Adam Reid

Trial Description: Medical Device Intervention

Background: Surgical reconstruction is required following peripheral nerve injury. Standard procedures involve the use of a patient’s own nerve tissue, that carries with it fundamental problems. This feasibility study uses a biodegradable conduit to determine improved nerve function, while assessing this composition as a clinically relevant biomaterial.

Main Outcomes: This study aims to determine if a novel synthetic nerve conduit is a viable, safe biomaterial to improve nerve repair and regeneration following peripheral nerve injury.

Patients to be recruited: 17

Status: Follow-up

CTU: Manchester CTU

Funder: National Institute for Health Research

Further Information: adam.reid@manchester.ac.uk